1α,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 140, Issue , 2014, Pages 26-33

  Pilon, Catia ^a   Urbanet, Riccardo ^a   Williams, Tracy A ^b   Maekawa, Takashi ^c   Vettore, Silvia ^a   Sirianni, Rosa ^d   Pezzi, Vincenzo ^d   Mulatero, Paolo ^b   Fassina, Ambrogio ^a   Sasano, Hironobu ^c   Fallo, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Adrenocortical cancer; H295R cells; Vitamin D

Indexed keywords

CALCITRIOL; CYCLIN DEPENDENT KINASE 4; VITAMIN D RECEPTOR;

ADRENAL CORTEX CARCINOMA; ADULT; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY;

ADRENOCORTICAL CANCER; H295R CELLS; VITAMIN D;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 4; HUMANS; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 84889834699     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.11.008     Document Type: Article

References (42)

1. D. Feldman, J.W. Pike, and J.S. Adams Vitamin D third ed. 2011 Academic Press Amsterdam/Boston/Heidelberg/London/New York/Oxford/Paris/San Diego/San Francisco/Singapore/Sydney/Tokyo
2. J. Zhu, and H.F. DeLuca Vitamin D 25-hydroxylase - four decades of searching, are we there yet? Archives of Biochemistry and Biophysics 523 2012 30 36
3. C. Carlberg, S. Seuter, and S. Heikkinen The first genome-wide view of vitamin D receptor locations and their mechanism implications Anticancer Research 32 2012 271 282
4. C.J. Rosen, J.S. Adams, D. Bikle, D.M. Black, M.B. Demay, J.E. Manson, M.H. Murad, and C.S. Kovacs The nonskeletal effects of vitamin D: an Endocrine Society scientific statement Endocrine Reviews 33 2012 456 492
5. R. Bouillon, G. Eelen, L. Verlinden, C. Mathieu, G. Carmeliet, and A. Verstuyf Vitamin D and cancer Journal of Steroid Biochemistry and Molecular Biology 102 2006 156 162 (Pubitemid 44781185)
6. M.F. Holick Vitamin D deficiency New England Journal of Medicine 357 2007 266 281
7. L. Vuolo, C. Di Somma, A. Faggiano, and A. Colao Vitamin D and cancer Frontiers in Endocrinology (Lausanne) 3 2012 58 10.3389/fendo.2012.00058
8. 3 and its analogs in breast, prostate and colorectal cancer Endocrine Related Cancer 20 2013 R31 R47
9. G. Eelen, C. Gysemans, L. Verlinden, E. Vanoirbeek, P. De Clercq, D. Van Haver, C. Mathieu, R. Bouillon, and A. Verstuyf Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs Current Medicinal Chemistry 14 2007 1893 1910 (Pubitemid 47163407)
10. L. Yang, J. Ma, X. Zhang, Y. Fan, and L. Wang Protective role of the vitamin D receptor Cellular Immunology 279 2012 160 166
11. A. Hossein-Nezhad, M.F. Spira, and Holick Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial PLoS ONE 8 2013 e58725 10.1371/journal.pone.0058725
12. L. Zini, E. Porpiglia, and M. Fassnacht Contemporary management of adrenocortical carcinoma European Urology 60 2011 1055 1065
13. J. Lafemina, and M.F. Brennan Adrenocortical carcinoma: past, present, and future Journal of Surgical Oncology 106 2012 586 594
14. R. Sirianni, F. Zolea, A. Chimento, C. Ruggiero, L. Cerquetti, F. Fallo, C. Pilon, G. Arnaldi, G. Carpinelli, A. Stigliano, and V. Pezzi Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment Journal of Clinical Endocrinology and Metabolism 97 2012 E2238 E2250
15. I. Erdogan, T. Deutschbein, C. Jurowich, M. Kroiss, C. Ronchi, M. Quinkler, J. Waldmann, H.S. Willenberg, F. Beuschlein, C. Fottner, S. Klose, A. Heidemeier, D. Brix, W. Fenske, S. Hahner, J. Reibetanz, B. Allolio, M. Fassnacht, and German Adrenocortical Carcinoma Study Group The role of surgery in the management of recurrent adrenocortical carcinoma Journal of Clinical Endocrinology and Metabolism 98 2013 181 191
16. J. Lundqvist, M. Norlin, and K. Wikvall 1alpha,25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells Biochimica et Biophysica Acta 1801 2010 1056 1062
17. W.E. Rainey, I.M. Bird, and J.I. Mason The NCI-H295 cell line: a pluripotent model for human adrenocortical studies Molecular and Cellular Endocrinology 100 1994 45 50 (Pubitemid 24109525)
18. T. Wang, and W.E. Rainey Human adrenocortical cell lines Molecular and Cellular Endocrinology 351 2012 58 65
19. L.M. Weiss, L.J. Medeiros, and A.L. Vickery Pathologic features of prognostic significance in adrenocortical carcinoma American Journal of Surgical Pathology 13 1989 202 206 (Pubitemid 19081702)
20. S. Aubert, A. Wacreiner, X. Leroy, P. Devos, B. Carnaille, C. Proye, J.L. Wemeau, M. Lecomte-Houcke, and E. Leteurtre Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors American Journal of Surgical Pathology 26 2002 1612 1619 (Pubitemid 35387224)
21. M. Volante, E. Bollito, P. Sperone, V. Tavaglione, F. Daffara, F. Porpiglia, M. Terzolo, A. Berruti, and M. Papotti Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification Histopathology 55 2009 535 543
22. G. Milan, C. Dalla Nora, C. Pilon, C. Pagano, M. Granzotto, M. Manco, G. Mingrone, and R. Vettor Changes in muscle myostatin expression in obese subjects after weight loss Journal of Clinical Endocrinology and Metabolism 89 2004 2724 2727 (Pubitemid 38766356)
23. T.V. Potapova, and L.J. Boitzova Structure, function, regulation: experimental analysis in groups of non-excitable cells coupled via permeable junctions Membrane and Cell Biology 11 1998 817 829 (Pubitemid 28383081)
24. C.A. Schneider, W.S. Rasband, and K.W. Eliceiri NIH Image to ImageJ: 25 years of image analysis Nature Methods 9 2012 671 675
25. T.A. Williams, S. Monticone, F. Morello, C.C. Liew, G. Mengozzi, C. Pilon, S. Asioli, A. Sapino, F. Veglio, and P. Mulatero Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro Hypertension 55 2010 1468 1475
26. T.A. Williams, S. Monticone, V. Crudo, R. Warth, F. Veglio, and P. Mulatero Visinin-like is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis Hypertension 59 2012 833 839
27. R. Morimoto, F. Satoh, O. Murakami, T. Suzuki, T. Abe, M. Tanemoto, M. Abe, A. Uruno, S. Ishidoya, Y. Arai, K. Takahashi, H. Sasano, and S. Ito Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas Endocrine Journal 55 2008 49 55 (Pubitemid 351520179)
28. M.F. Holick Vitamin D status: measurement, interpretation, and clinical application Annals of Epidemiology 19 2009 73 78
29. Z.E. Davidson, K.Z. Walker, and H. Truby Do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies Journal of Clinical Endocrinology and Metabolism 97 2012 738 744 (clinical review)
30. D. Carrara, M. Bernini, A. Bacca, I. Rugani, E. Duranti, A. Virdis, L. Ghiadoni, S. Taddei, and G. Bernini Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D Journal of Renin Angiotensin Aldosterone System 2013 (in press)
31. U. Berger, P. Wilson, A. McClelland, K. Colston, M.R. Haussler, J.W. Pike, and R.C. Coombes Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues Journal of Clinical Endocrinology and Metabolism 67 1988 607 613
32. D.G. Romero, E.P. Gomez-Sanchez, and C.E. Gomez-Sanchez Angiotensin II-regulated transcription regulatory genes in adrenal steroidogenesis Physiological Genomics 42A 2010 259 266
33. D.M. Peehl, R.J. Skowronski, G.K. Leung, S.T. Wong, T.A. Stamey, and D. Feldman Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells Cancer Research 54 1994 805 810 (Pubitemid 24068341)
34. F. Fallo, C. Pilon, L. Barzon, M. Pistorello, U. Pagotto, G. Altavilla, M. Boscaro, and N. Sonino Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell line Chemotherapy 44 1998 129 134 (Pubitemid 28105426)
35. S.S. Jensen, M.W. Madsen, J. Lukas, L. Binderup, and J. Bartek Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery Molecular Endocrinology 15 2001 1370 1380 (Pubitemid 32703484)
36. J.N. Artaza, F. Sirad, M.G. Ferrini, and K.C. Norris 1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells Journal of Steroid Biochemistry and Molecular Biology 119 2010 73 83
37. M. Kroiss, M. Quinkler, W.K. Lutz, B. Allolio, and M. Fassnacht Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma Clinical Endocrinology (Oxford) 75 2011 585 591
38. Z. Wang, E.G. Schuetz, Y. Xu, and K.E. Thummel Interplay between vitamin D and the drug metabolizing enzyme CYP3A4 Journal of Steroid Biochemistry and Molecular Biology 136 2013 54 58
39. L. Cerquetti, B. Bucci, R. Marchese, S. Misiti, U. De Paula, R. Miceli, A. Muleti, D. Amendola, P. Piergrossi, E. Brunetti, V. Toscano, and A. Stigliano Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines Endocrine-Related Cancer 15 2008 623 634 (Pubitemid 351880848)
40. T. Michigami, A. Suga, M. Yamazaki, C. Shimizu, G. Cai, S. Okada, and K. Ozono Identification of amino acid sequence in the hinge region of human vitamin D receptor that transfers a cytosolic protein to the nucleus Journal of Biological Chemistry 274 1999 33531 33538 (Pubitemid 129511662)
41. K.L. Sunn, T.A. Cock, L.A. Crofts, J.A. Eisman, and E.M. Gardiner Novel N-terminal variant of human VDR Molecular Endocrinology 15 2001 1599 1609 (Pubitemid 32826412)
42. F.S. Cheung, F.J. Lovicu, and J.K. Reichardt Current progress in using vitamin D and its analogs for cancer prevention and treatment Expert Review of Anticancer Therapy 12 2012 811 837